Igyxos Biotherapeutics
PrivateLast Round
Grant
Oct 2, 2025
Total Funding Raised
$20.58M
Company Overview
Igyxos Biotherapeutics operates in Healthcare & Life Sciences and is based in Nouzilly. Its latest recorded funding round was a Grant round in October 2025.
Igyxos Biotherapeutics is a biotechnology company that develops monoclonal antibody-based therapeutics to treat infertility in men and women.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igyxos Biotherapeutics Comparables
Compare Igyxos Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxolife | 78% | |
| Granata Bio | 76% | |
| Merck | 73% |
For institutional investors. Book with your work email.
Igyxos Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 2, 2025 | ||||
| VC Round | Nov 14, 2023 | ||||
| Debt | Nov 14, 2023 | ||||
| Series A | Mar 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Igyxos Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Social Impact Enterprises | VC Round |
| UI Investissement | VC Round |
| Sofimac Innovation | Series A |
| GO Capital | VC Round, Series A |
| Sofimac Investment Managers | VC Round |
| Bpifrance | Debt, VC Round, Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 1871% MoM, reaching 2.5K.
- Nov 14, 2023
$12.3M raised from Sofimac, UI Investissement, GO Capital, Bpifrance, and Social Impact Enterprises.
For institutional investors. Book with your work email.
Igyxos Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Igyxos Biotherapeutics's valuation, stock price, and market status.
Is Igyxos Biotherapeutics a public or private company?
Igyxos Biotherapeutics is a private company.
What is the current stock price of Igyxos Biotherapeutics?
Igyxos Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Igyxos Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Igyxos Biotherapeutics worth (valuation)?
Valuation information for Igyxos Biotherapeutics is not publicly available.
Can I buy Igyxos Biotherapeutics stock?
Igyxos Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Igyxos Biotherapeutics's last funding round?
Igyxos Biotherapeutics's most recent funding round was Grant on October 2, 2025.
Who are the main investors in Igyxos Biotherapeutics?
Key investors in Igyxos Biotherapeutics include Bpifrance.
Will Igyxos Biotherapeutics IPO soon?
No public IPO plans have been announced for Igyxos Biotherapeutics.
How can I track Igyxos Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Igyxos Biotherapeutics's shares on secondary markets.